Fiebo J.W. ten Kate

Erasmus MC — Netherlands

Medicine · Health Sciences

57h-index15.3kcitations150works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Esophageal Cancer Research and Treatment(58), Gastric Cancer Management and Outcomes(53), Esophageal and GI Pathology(32), Pancreatic and Hepatic Oncology Research(14), Cervical Cancer and HPV Research(12)

Publications150 total

Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
Journal of Clinical Oncology·2021· 712 citedOpen Access
10-year Outcome of a Randomized Trial Comparing Neoadjuvant Chemoradiotherapy and Surgery with Surgery Alone for Esophageal Cancer (CROSS trial)
2021
Tissue Systems Pathology Test Objectively Risk Stratifies Barrett's Esophagus Patients With Low-Grade Dysplasia
The American Journal of Gastroenterology·2020· 39 citedOpen Access
O200 10-YEAR FOLLOW-UP OF A RANDOMISED CONTROLLED TRIAL COMPARING NEOADJUVANT CHEMORADIOTHERAPY PLUS SURGERY VERSUS SURGERY ALONE FOR OESOPHAGEAL OR JUNCTIONAL CANCER (CROSS)
Diseases of the Esophagus·2019
Improved Progression Prediction in Barrett’s Esophagus With Low-grade Dysplasia Using Specific Histologic Criteria
The American Journal of Surgical Pathology·2018· 18 cited
Effect of Neoadjuvant Chemoradiotherapy on Health-Related Quality of Life in Esophageal or Junctional Cancer: Results From the Randomized CROSS Trial
Journal of Clinical Oncology·2017· 121 citedOpen Access
Patients With Barrett’s Esophagus and Confirmed Persistent Low-Grade Dysplasia Are at Increased Risk for Progression to Neoplasia
Gastroenterology·2016· 108 cited
Dynamic clonal equilibrium and predetermined cancer risk in Barrett’s oesophagus
Nature Communications·2016· 94 citedOpen Access
The Oncological Value of Omentectomy in Gastrectomy for Cancer
Journal of Gastrointestinal Surgery·2016· 46 citedOpen Access
Prognostic Value of Pretreatment Pathological Tumor Extent in Patients Treated With Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal or Junctional Cancer
Annals of Surgery·2016· 39 citedOpen Access
Profiling of circulating microRNAs in patients with Barrett’s esophagus and esophageal adenocarcinoma
Journal of Gastroenterology·2015· 70 citedOpen Access
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
The Lancet Oncology·2015· 2.5k cited
Derivation of genetic biomarkers for cancer risk stratification in Barrett’s oesophagus: a prospective cohort study
Gut·2015· 52 citedOpen Access
Prolonged Time to Surgery After Neoadjuvant Chemoradiotherapy Increases Histopathological Response Without Affecting Survival in Patients With Esophageal or Junctional Cancer
Annals of Surgery·2014· 93 citedOpen Access
Barrett's oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel
Gut·2014· 278 citedOpen Access
Surveillance of Barrett's Esophagus and Mortality from Esophageal Adenocarcinoma: A Population-Based Cohort Study
The American Journal of Gastroenterology·2014· 154 cited
Radiofrequency Ablation vs Endoscopic Surveillance for Patients With Barrett Esophagus and Low-Grade Dysplasia
JAMA·2014· 629 citedOpen Access
Whole slide images for primary diagnostics of urinary system pathology: a feasibility study.
PubMed·2014· 33 citedOpen Access
Exogenous Pigment in Peyer Patches of Children Suspected of Having IBD
Journal of Pediatric Gastroenterology and Nutrition·2013· 37 cited
Residual Esophageal Cancer after Neoadjuvant Chemoradiotherapy Frequently Involves the Mucosa and Submucosa
Annals of Surgery·2013· 82 cited
page 1 of 8Next →

Frequent Co-authors

Jacques Bergman(16), Paul Fockens(14), J. Jan B. van Lanschot(13), Olivier R. Busch(8), Kausilia K. Krishnadath(8), Hugo W. Tilanus(7), Mike Visser(7), Mohammed A. Kara(7), Femke P. Peters(7), Mark I. van Berge Henegouwen(6), Pieter van Hagen(5), Herman van Dekken(5), Jan G.P. Tijssen(5), Sjoerd M. Lagarde(5), Bas L. Weusten(5), Sybren L. Meijer(5), G. Johan A. Offerhaus(5), Roos E. Pouw(5), Wilda Rosmolen(5), Joël Shapiro(4)